New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct. 2), and published in Diabetologia shows that the incidence (the new case rate) of type 1 diabetes (T1D) in children ages 0.5–5 years in Norway was 11% higher following the rapid rollout and uptake of the rotavirus vaccine in September 2014. The study is by doctoral student Maria Östman, University of Oslo, Oslo, Norway, and colleagues.
Study Examines Potential Link Between Rotavirus Vaccination and Type 1 Diabetes Incidence
A study presented at the EASD meeting found an 11% increase in type 1 diabetes incidence in Norwegian children following the introduction of the rotavirus vaccine. The research, led by Maria Östman from the University of Oslo, raises questions about vaccine effects. This could influence vaccine policy discussions in Iran, particularly regarding public health and vaccination programs.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%